Compliance Strategy for Small to Midsized Companies

February 22, 2013

 

Published for Pharmaceutical Compliance Monitor

On Feb. 20, 2013, Jim Hoover’s article, “Compliance Strategy for Small to Midsized Companies,” published in the online version of Pharmaceutical Compliance Monitor. In the article, Jim discusses the basic steps that small to mid-sized pharmaceutical companies should take when conducting an internal investigation. He instructs  companies to carefully consider the scope and limits of the investigation, who should conduct the investigation, how to protect the relevant privileges, and the possible outcomes of the investigation, prior to conducting the investigation. By fully considering these factors, Jim suggests that companies will be in a better position to correct any problems identified and determine whether or not self-disclosure is warranted. For the full article, please click here.  





Legal Disclaimer:
No representation is made that the quality of services to be performed is greater than the quality of legal services performed by other lawyers.

Featured Attorneys

send article

TESTIMONIALS

  • “Very much a documentation person. She is behind the scenes and explains things very well. She...has wonderful skills.”

    -Chambers 2012

  • "I have worked with the Burr & Forman people in Atlanta, Birmingham and Orlando and they are consistently the best around. Their fees tend to come in under similar firms and their work product is superior."

    -Best Lawyers 2012

  • "Burr & Forman provides outstanding representation in all areas."

    -Best Lawyers 2012

  • "We have had very positive experiences with them. I tend to think very well of the firm. They have been very good: I always feel like I'm getting extra support because the case has been handled efficiently."

    -Chambers 2013

  • “I would single him out as a wonderful leader.”

    -Chambers 2012